PreMarket Price
PreMarket Price
Molina Healthcare, Inc. (MOH) logo

Stock Analysis

Molina Healthcare, Inc.MOH

Price:$207.36Market Closed-2.42%at last close

Sector: Financial Services · Industry: Hospital & Medical Service Plans

AnalystsHold25 analysts
EW Score 35/65 · #218Mkt Cap 10.82BROE -0.2%
Low $122.65$207.36High $242.88

Price is 70% of the way from the year's low to its high.

Cash $8.26BNet cash $4.49BDebt $3.77B

Cash covers 219% of debt · FY 2025.

Profilev45g20p5h93q47m23

PMP Verdict

Cheap for a reason — weak fundamentals

Strengths

  • Financial Health93

Risks

  • Profitability5
  • Growth20
Revenue +13.1% CAGRP/S 22nd percentile

Cheap for a reason — fundamentals remain weak.

Market context

-2.4% today· Z 1.3σ

Bull Case

  • ✓Altman Z 4.4 — safe-zone balance sheet
  • ✓Revenue CAGR 13.1% — durable top-line growth
  • ✓Interest coverage 15.8× — debt well covered

What's happening with MOH

Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3? — Yahoo, 11h agoLast big move: +5.0% on 2026-10-12

Profile

Valuation — 45/100 (Weak) P/E vs own history: n/a → 10/25 FCF yield: 2.5% → 5/25 P/S: 0.2x → 25/25 EV/EBIT: 31.2x → 5/25Valuation45Growth — 20/100 (Weak) Revenue CAGR: 13.1% → 20/25 Net income CAGR: -8.0% → 0/25 EPS CAGR 5Y: -5.6% → 0/25 Fwd implied growth: n/a → 0/25Growth20Profitability — 5/100 (Weak) ROIC: n/a → 0/25 ROE: -0.2% → 0/25 Net margin: -0.0% → 0/25 Operating margin: 0.5% → 5/25Profitability5Financial Health — 93/100 (Strong) Altman Z: 4.37 → 25/25 Current ratio: 1.69 → 18/25 Interest coverage: 15.8x → 25/25 Net cash / debt: Net cash → 25/25Health93Quality — 47/100 (Weak) Piotroski F: 4/9 → 10/25 Beneish M: -2.16 → 12/25 FCF conversion: -3871% → 0/25 Margin stability: σ 2.4% → 25/25Quality47Moat — 23/100 (Weak) ROIC >12% years: n/a → 0/25 Median gross margin: 14.8% → 0/25 FCF-positive years: 8/10 yrs → 18/25 Worst-year net margin: worst -2.6% → 5/25Moat23

Strong financial health; profitability, growth, moat, valuation and earnings quality lag behind.

How is each axis scored?
  • Valuation45/100 · Weak
    • P/E vs own history (n/a)10/25
    • FCF yield (2.5%)5/25
    • P/S (0.2x)25/25
    • EV/EBIT (31.2x)5/25
  • Growth20/100 · Weak
    • Revenue CAGR (13.1%)20/25
    • Net income CAGR (-8.0%)0/25
    • EPS CAGR 5Y (-5.6%)0/25
    • Fwd implied growth (n/a)0/25
  • Profitability5/100 · Weak
    • ROIC (n/a)0/25
    • ROE (-0.2%)0/25
    • Net margin (-0.0%)0/25
    • Operating margin (0.5%)5/25
  • Financial Health93/100 · Strong
    • Altman Z (4.37)25/25
    • Current ratio (1.69)18/25
    • Interest coverage (15.8x)25/25
    • Net cash / debt (Net cash)25/25
  • Quality47/100 · Weak
    • Piotroski F (4/9)10/25
    • Beneish M (-2.16)12/25
    • FCF conversion (-3871%)0/25
    • Margin stability (σ 2.4%)25/25
  • Moat23/100 · Weak
    • ROIC >12% years (n/a)0/25
    • Median gross margin (14.8%)0/25
    • FCF-positive years (8/10 yrs)18/25
    • Worst-year net margin (worst -2.6%)5/25

About Molina Healthcare, Inc.

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. Show more

The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.

Headquarters: LONG BEACH, CA · Employees: 19,000 · Website ↗

Price History

Weekly Candlestick Chart — up to 5Y

Key Metrics

Financial snapshot · Tap any metric for its definition and grade

TTM Snapshot

trailing twelve months · YoY
Revenue
44.5B+3%
Op. Income
203M-88%
Net Income
-7M-101%
EPS
-0.14-101%
Operating CF
365M-32%
Free CF
271M-37%

Valuation

45D+
P/E (TTM)—

Price / TTM EPS (own statements)

P/FCF10.5xA

Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative

FCF Yield2.5%C

Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: -8.8%–17.5% · 28th pct

P/S (TTM)0.24xA

Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 0.1x–0.8x · 22nd pct

EV/EBIT31.2xD

Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 1.5x–39.2x · 96th pct

EV/Sales0.2xA

Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E39.6xD

Grade D: ExpensivePrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio2.66xA

Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio—

Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield—

TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio—

Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

Profitability

5E
ROIC—

NOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE-0.2%D

Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks

ROA-0.0%D

Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin-0.0%D

Grade D: LowNet Income / Revenue

Operating Margin0.5%D

Grade D: LowTTM EBIT / TTM Revenue

Gross Margin12.6%D

Grade D: LowGross Profit / Revenue

FCF Margin0.6%D

Grade D: LowFCF / Revenue

True FCF Margin0.4%D

Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost

Growth

20E
Revenue CAGR13.1%C

Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR-8.0%D

Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)-5.6%D

Grade D: LowCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth—

Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth

Dilution (5Y)-10.9%A

Grade A: BuybacksShare count change over 5Y

SBC / Net Income—

Stock-based comp/Net income. >30% = dilution risk

SBC / Revenue0.2%A

Grade A: LowTTM stock-based comp / TTM Revenue

Financial Health

93A+
Altman Z-Score4.37A

Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio1.69xC

Grade C: OkCurrent Assets/Liabilities

Quick Ratio1.61xA

Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage15.8xA

Grade A: StrongEBIT/Interest. >10 Strong

Debt RepaymentNet CashA

Grade A: FastYears to repay net debt via FCF

Net Debt/EBITNet CashA

Grade A: LowLeverage. <2x Low, >4x High

Debt/Equity0.93xA

Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt2.19xA

Grade A: CoveredCash covers how much of total debt. >1 = could repay all debt from cash

Quality

47D+
Piotroski F-Score4/9C

Grade C: AverageFinancial strength 0–9. >7 Strong

Beneish M-Score-2.16C

Grade C: Gray zoneEarnings manipulation risk. < -2.22 Safe

FCF Conversion-3871.4%D

Grade D: PoorFCF / Net Income

Margin Stability2.4%A

Grade A: StableEBIT margin std deviation. Lower = stable

Capex / Revenue0.2%A

Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover2.80xA

Grade A: HighRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

1/10 Loss Years

Insider Transactions

SEC Form 4 · 8 records
Open-market · 90dBuy —Sell —Other filings 9No open-market trades

P/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.

Recent insider transactions
Trade dateTransactionShares
Lockhart Stephen H
Filed
Grant / award
+304
Schapiro Richard M
Filed
Grant / award
+304
ZORETIC RICHARD C
Filed
Grant / award
+304
GROHOWSKI LEO P
Filed
Grant / award
+304
SOISTMAN FRANCIS S JR
Filed
Grant / award
+304
Show 3 more filings
Additional recent insider transactions
Trade dateTransactionShares
WOLF DALE B
Filed
Grant / award
+304
ORLANDO STEVEN J
Filed
Grant / award
+304
ROMNEY RONNA
Filed
Grant / award
+304
More metrics — Moat, Per Share, Balance Sheet, Market

Moat

23E
ROIC >12% Years—

Share of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability

Gross Margin (Med.)14.8%D

Grade D: WeakMedian annual gross margin across available fiscal years — pricing-power durability

FCF-Positive Years8/10 yrsA

Grade A: DurableShare of completed fiscal years with positive free cash flow

Net Margin Floor-2.6%D

Grade D: WeakWeakest annual net margin across completed fiscal years — recession/downcycle resilience

Per Share

EPS (TTM)—

TTM net income per share (Finnhub fallback)

Cash / Share$171.44

Cash & short-term investments per share (Finnhub)

Book Value / Share$80.21

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt$3.77B

Total debt obligations (short + long term)

Cash & Equiv.$8.26B

Cash and short-term investments

Net Debt$-4.49BA

Grade A: Net CashTotal Debt minus Cash. Negative = Net Cash position

Total Equity$4.07B

Shareholders' equity (book value)

Asset / Liability1.35xC

Grade C: AdequateTotal Assets / Total Liabilities

Market

Market Cap$10.82B

Current Market Capitalization

Beta0.74B

Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026

Key Insights: Molina Healthcare, Inc. (MOH)

MOH is down 2.42% at the last close. Piotroski F-Score of 4/9 indicates mixed fundamentals for Molina Healthcare, Inc.. Altman Z-Score of 4.37 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk.

  • Company is effectively debt-free after netting cash.
  • Molina Healthcare, Inc. posted a net loss in 1 of 10 available completed fiscal years (2016–2025).

See how MOH ranks on the Capex Tracker — top 50 capital spenders compared.

Recent Market Moves

See all MOH moves →
DateSessionPriceMoveZ-Score
Oct 12Regular206.84+5.03%2.46
Oct 12After-hours208.35+5.80%2.80
Oct 2Regular188.62+4.30%2.08
Oct 2After-hours189.54+4.81%2.29

Frequently Asked Questions about MOH

What is the current Molina Healthcare, Inc. (MOH) stock price?

MOH is trading at $207.36 at the last market close, down 2.42% on the session. PreMarketPrice tracks MOH pre-market, intraday and after-hours prices.

Is MOH stock a buy right now?

PreMarketPrice's quantitative model rates Molina Healthcare, Inc.'s financial health at 93/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is MOH stock overvalued?

Molina Healthcare, Inc. trades at a trailing P/E of n/a and our valuation score rates it 45/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does Molina Healthcare, Inc. report earnings?

No confirmed earnings date is currently scheduled for MOH. The Earnings section lists recent reports and updates as dates are announced.

What sector does Molina Healthcare, Inc. operate in?

Molina Healthcare, Inc. operates in the Financial Services sector, within the Hospital & Medical Service Plans industry. The Related Stocks section lists sector peers for comparison.

What does Molina Healthcare, Inc. do?

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare.

About Molina Healthcare, Inc. (MOH) Stock

Molina Healthcare, Inc. (MOH) is a US-listed stock operating in the Financial Services sector, specifically the Hospital & Medical Service Plans industry. As of the latest update, Molina Healthcare, Inc. is trading at $207.36, down 2.42% on the day with a market capitalization of $10.8 billion. The financial health score for MOH is 93/100, which indicates excellent financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for MOH stock.

MOH Stock Analysis & Key Metrics

On PreMarketPrice, you can track Molina Healthcare, Inc. (MOH) across multiple dimensions:

Is MOH a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate Molina Healthcare, Inc. (MOH) as an investment. The financial health score of 93/100 suggests excellent financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Molina Healthcare, Inc. (MOH) trades on NYSE. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.

Related opportunities

Moving today in Financial Services
More Hospital & Medical Service Plans stocks
Cheaper alternatives
Similar fundamentals